MMP9 and Myocardial fibrosis: The results suggest that administration of valsartan inhibited the expression of fibrosis-related proteins TGF-β, MMP-2 and MMP-9, which may reduce the accumulation of collagen and further prevent the enlargement of myocardial fibrosis.